These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5547410)

  • 21. Coexistence of MEN 2A and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery: report of a case and a review of the Japanese literature.
    Oishi S; Sasaki M; Sato T; Isogai M
    Jpn J Clin Oncol; 1995 Aug; 25(4):153-8. PubMed ID: 7666591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologic considerations and operative strategy in papillary thyroid carcinoma: arguments against the routine performance of total thyroidectomy.
    Cohn KH; Bäckdahl M; Forsslund G; Auer G; Zetterberg A; Lundell G; Granberg PO; Löwhagen T; Willems JS; Cady B
    Surgery; 1984 Dec; 96(6):957-71. PubMed ID: 6505969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
    Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and significance of c-met protein in papillary thyroid carcinoma.
    Inaba M; Sato H; Abe Y; Umemura S; Ito K; Sakai H
    Tokai J Exp Clin Med; 2002 Aug; 27(2):43-9. PubMed ID: 12472169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaplastic cancer, lymphoma, and metastases of the thyroid gland.
    Pasieka JL
    Surg Oncol Clin N Am; 1998 Oct; 7(4):707-20. PubMed ID: 9735130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of postirradiation thyroid nodules--too much or too little?
    Wexler MJ
    Can J Surg; 1980 Nov; 23(6):507-9. PubMed ID: 7448653
    [No Abstract]   [Full Text] [Related]  

  • 27. Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10.
    Stassi G; Todaro M; Zerilli M; Ricci-Vitiani L; Di Liberto D; Patti M; Florena A; Di Gaudio F; Di Gesù G; De Maria R
    Cancer Res; 2003 Oct; 63(20):6784-90. PubMed ID: 14583474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma.
    Yamashita H; Noguchi S; Murakami N; Kawamoto H; Watanabe S
    Cancer; 1997 Dec; 80(12):2268-72. PubMed ID: 9404704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bone risk of hormone-suppressing therapy in differentiated thyroid epithelioma. Study by dual photon absorptiometry].
    Leprat F; Austyn C; Commenges-Ducos M; Commenges D; Cochet C; Basse-Catalinat B; Ducassou D; Latapie JL
    Ann Endocrinol (Paris); 1992; 53(5-6):224-9. PubMed ID: 1340689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Papillary microcarcinoma of the thyroid gland].
    Soliman T
    Wien Klin Wochenschr; 1993; 105(20):591-4. PubMed ID: 8259688
    [No Abstract]   [Full Text] [Related]  

  • 31. [Present-day therapeutic methods in thyroid carcinoma].
    Skrzypek J; Wasylewski A
    Pol Przegl Chir; 1979 Jan; 51(1):81-5. PubMed ID: 461247
    [No Abstract]   [Full Text] [Related]  

  • 32. [Main causes of reoperation in patients with thyroid cancer].
    Romanchisen AF
    Vestn Khir Im I I Grek; 1998; 157(2):11-3. PubMed ID: 9691372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Principles of thyroid hormone treatment (author's transl)].
    Pfannenstiel P
    MMW Munch Med Wochenschr; 1980 Jun; 122(26):961-6. PubMed ID: 6775193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
    Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD
    Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anaplastic transformation of papillary carcinoma of the thyroid].
    Gál I; Hatházi L; Nemes Z; Solymosi T
    Orv Hetil; 1994 Mar; 135(11):581-4. PubMed ID: 8159411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pure follicular thyroid carcinoma: impact of therapy in 214 patients.
    Young RL; Mazzaferri EL; Rahe AJ; Dorfman SG
    J Nucl Med; 1980 Aug; 21(8):733-7. PubMed ID: 7400828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Survival potentials of patients with papillary carcinoma of the thyroid gland in Hungary].
    Esik O; Tusnády G; Daubner K; Németh G; Füzy M; Szentirmay Z
    Orv Hetil; 1996 May; 137(20):1067-78. PubMed ID: 8657418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inoperable thyroid carcinoma: palliation with percutaneous injection of ethanol.
    Goletti O; Lenziardi M; De Negri F; Fiorini I; Lippolis PV; Cristofani E; Di Coscio G; Seccia M; Cavina E
    Eur J Surg; 1993; 159(11-12):639-41. PubMed ID: 7510524
    [No Abstract]   [Full Text] [Related]  

  • 40. Disseminated follicular eruption during therapy with the MEK inhibitor AZD6244.
    Querfeld C; Duffy K; Magel G; Oble D; Cohen EE; Shea CR
    J Am Acad Dermatol; 2011 Feb; 64(2):e17-9. PubMed ID: 21238821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.